Skip to Main Content

Paper Details

CODEL: phase III study of RT, RTâ¿¿+ TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design.
Neuro Oncol
52
2021
1p/19q, 1p/19q codeleted, CODEL, IDH, PCV, RT arms, TMZ, arms, isocitrate, isocitrate dehydrogenase, oligodendroglioma, patients, temozolomide
Author NameAffiliation
Caterina GianniniMayo Clinic
Caterina GianniniMayo Clinic
Michael WellerUniversity Hospital and University of Zurich
Kenneth AldapeThe University of Texas MD Anderson Cancer Center
Kenneth AldapeThe University of Texas MD Anderson Cancer Center
David SchiffUniversity of Virginia
Michael A VogelbaumCleveland Clinic
  • 1 - 7

Datasets

Release 1.2